BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

21 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
24
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.EBI
Bristol Myers Squibb
27
Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa Inhibitors.EBI
Bristol Myers Squibb
9
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.EBI
Bristol Myers Squibb
13
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.EBI
Bristol Myers Squibb
11
Atropisomer Control in Macrocyclic Factor VIIa Inhibitors.EBI
Bristol Myers Squibb
36
Applications of Fluorine in Medicinal Chemistry.EBI
Bristol Myers Squibb
14
Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors.EBI
TBA
28
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.EBI
Bristol Myers Squibb
33
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.EBI
Pfizer
23
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.EBI
Laboratory of Molecular Biology, Medical Research Council
55
Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate.EBI
F. Hoffmann-La Roche
19
Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands.EBI
Astellas Pharma
7
Potent 4-amino-5-azaindole factor VIIa inhibitors.EBI
Celera Genomics
11
Factor VIIa inhibitors: improved pharmacokinetic parameters.EBI
Celera Genomics
9
Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.EBI
Celera Genomics
30
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.EBI
Pfizer
5
A score years' update in the synthesis and biological evaluation of medicinally important 2-pyridones.EBI
Chaudhary Charan Singh Haryana Agricultural University
14
Optimization of a screening lead for factor VIIa/TF.EBI
Axys Pharmaceuticals
15
Discovery of novel P1 groups for coagulation factor VIIa inhibition using fragment-based screening.EBI
Bristol Myers Squibb
12
Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs.EBI
University of Nottingham
40
The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.EBI
Hefei University of Technology